Establishing secure connection…Loading editor…Preparing document…

Healthcare MedTech Research Consent Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Healthcare MedTech Research Consent Form

Study and Investigator Information

Study Title:

Principal Investigator:

Affiliated Institution:

Participant Information

Insurance Information

Medical History

Description of Research and Procedures

You are being asked to participate in a research study of a medical technology product. The following describes the procedures that may be used during this study and what you will be asked to do.

Risks, Discomforts, and Potential Benefits

Alternatives and Compensation

Alternatives to participation include receiving standard care without participation in this research. You may discuss alternatives with the study team and your treating clinician.

Confidentiality, Data Use, and Commercialization

The research team will collect health information and device-generated data as described above. Reasonable efforts will be made to protect your information; however, absolute confidentiality cannot be guaranteed. Data may be stored, analyzed, and retained for future research in de-identified or coded form.

Device signals (sensors, physiologic data)    Electronic health record data    Photographic or video images    Survey or questionnaire responses

De-identified data may be shared with collaborators    Identifiable data may be shared with partner organizations (limited)    Data or results may be used for commercialization or product development

If identifiers are shared, the research team will use reasonable safeguards. If data are shared for commercial purposes, you will not necessarily receive royalties or ongoing financial benefit.

Voluntary Participation and Withdrawal

Your participation is voluntary. You may refuse to participate or may withdraw at any time without penalty or loss of benefits to which you are otherwise entitled. If you withdraw, the research team may retain data collected prior to withdrawal to preserve study integrity unless you specifically request deletion and it is practicable to do so.

HIPAA Authorization for Use and Disclosure of Protected Health Information

I authorize the use and disclosure of my protected health information as described below for the purposes of this research study. This authorization permits the research team to obtain and use my medical records and related information relevant to the study.

I understand that I may revoke this authorization at any time by providing a written notice to the Principal Investigator, except to the extent that action has already been taken in reliance on this authorization.

Participant Acknowledgments (initial or check each)

I have read (or had read to me) the information in this consent form and I understand the nature and purpose of the research.

My questions about the study have been answered to my satisfaction.

I understand I may withdraw from the study at any time without penalty.

I understand the privacy and data use risks described above.

I understand that data may be used for commercial product development and that I may not receive financial benefit from such use.

Contacts for Questions or Concerns

Consent and Signature

By signing below, I voluntarily agree to participate in this study and to the uses and disclosures of my protected health information as described above. I have received a copy of this consent form, and I acknowledge that participation is voluntary.

Participant Name:

Signature:

Date:

If signed by guardian, Relationship to Participant:

Enter text✕

What the Healthcare MedTech Research Consent Form Is

The Healthcare MedTech Research Consent Form documents a participant's informed agreement to take part in a medical technology study or device evaluation. It summarizes the study purpose, procedures, risks, benefits, data use and retention, and any permission to access or share protected health information. For electronic execution, the form must meet the ESIGN Act (15 U.S.C. ch. 96) and applicable state UETA or ESRA rules, and it should include HIPAA-compliant language and a BAAsupported workflow when PHI is exchanged. The form establishes legal permissions and participant expectations for the research.

Why a Proper Consent Form Matters

A complete, compliant consent form reduces regulatory risk, protects participant rights, and provides clear documentation of consent for research oversight and audits. It also clarifies data-sharing parameters, supports IRB review, and demonstrates adherence to HIPAA and federal e-signature standards.

Why a Proper Consent Form Matters

Who Completes and Signs This Form

Roles vary by study and site; document signatory authority should be confirmed before execution to ensure validity.

  • Principal investigators and study staff responsible for obtaining informed consent and documenting procedures and risks.
  • Study participants or legally authorized representatives signing on behalf of a consenting adult or minor.
  • Institutional review boards and compliance officers reviewing consent language and retention requirements.

Step-by-Step: How to Obtain Valid Consent

Complete the form in a consistent order to document consent clearly and reduce follow-up.

  • 01
    Prepare: Confirm IRB-approved text and HIPAA addendum are attached.
  • 02
    Verify Identity: Match participant name and DOB to acceptable ID.
  • 03
    Explain: Walk through risks, benefits, and alternatives verbally.
  • 04
    Sign: Collect dated signature and record method of signature (electronic or wet ink).

Typical Electronic Consent Workflow

This sequence describes a common eConsent flow used for MedTech research projects.

  • Upload: Study staff uploads IRB-approved consent PDF to the e-sign platform.
  • Place Fields: Allocate signature, date, initials, and optional conditional fields.
  • Authenticate: Use email link, SMS code, or stronger identity checks before signing.
  • Archive: Store executed copy with audit trail and access controls.

How to Configure an Online Consent Workflow

Key configuration settings help ensure compliant collection and easy retrieval of signed consents.

Setting Recommended Value
Authentication Email + SMS or KBA for higher risk
Audit Trail Enable timestamps, IP, and signer metadata
Retention Automate export to secure archive after signing
Access Control Role-based permissions for study staff

Technical and Integration Considerations

Ensure the platform can support HIPAA BAAs and maintain auditable copies for compliance and IRB review.

  • Document formats: PDF, DOCX and structured HTML forms supported
  • Integrations: Connectors for EHRs, Google Workspace, NetSuite, Salesforce
  • Security: AES-256 at rest and TLS 1.2/1.3 in transit

Essential Security and Privacy Elements

Encryption: AES-256 at rest
Transport: TLS 1.2/1.3 in transit
Compliance: HIPAA BAA available
Audit Trail: Timestamps and signer metadata
Access Control: Role-based permissions
Certification: SOC 2 Type II available

Penalties and Legal Risks of Improper Consent

Regulatory fines: HIPAA penalties and corrective actions
Study suspension: IRB may halt research for noncompliance
Data breaches: Notification obligations and liabilities
Invalid consent: Withdrawn consent can invalidate collected data
Civil liability: Participant claims for harm
Reputational harm: Loss of trust and funding

Common Pitfalls to Avoid

  • Using non‑IRB‑approved consent text or out-of-date protocol versions that lead to inconsistent participant information and audit findings.
  • Failing to obtain explicit HIPAA authorization when study procedures involve access to protected health information or third-party data sharing.
  • Relying on weak authentication for remote signing that does not adequately link the signature to the signer’s identity for high-risk device testing.
  • Inadequate retention or archival practices that prevent retrieval of signed consents during monitoring or regulatory inspections.

Timelines and Processing Expectations

Track dates carefully: effective date, enrollment date, consent version, and retention milestones all affect compliance and recordkeeping.

Consent Effective Date:

Date participant signs; governs start of permissions

Version Control:

Record consent form version and IRB approval date

Enrollment Deadline:

Follow protocol-specific enrollment windows

Data Use Period:

Specify duration of data retention and access

Audit Availability:

Signed copies accessible during monitoring

eSignature Pricing and Feature Comparison

Compare starting price and basic feature availability across common eSignature providers; signNow is listed first per platform data.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial, no card No No Yes, limited Yes, limited
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Real-World Examples of Consent Use

Two concise examples illustrate how consent forms are used in MedTech trials.

Optica Ventures Clinical Pilot

Optica conducted a remote device usability study using an eConsent process approved by its IRB

  • The team used SMS and email authentication
  • The signed forms and audit trails were retained for monitoring and demonstrated compliance during a site audit.

Fertility Centers Implementation

A clinical network deployed an eSignature workflow for device evaluation across clinics

  • Integration with their practice management system simplified routing
  • The platform’s SOC 2 and HIPAA controls supported the network’s data protection requirements.

Practical Tips for Smooth Consent Collection

Adopt consistent procedures and templates to reduce errors and improve participant understanding.

Use Plain Language
Write consent explanations at a readable level and avoid technical terms without explanation to ensure informed decision-making.
Version Control
Track and display consent version and IRB approval dates to prevent use of outdated forms.
Authentication Strength
Match authentication to study risk: email or SMS for low risk; KBA or multi-factor for higher-risk device testing.
Secure Archival
Store signed copies with role-based access, tamper-evident storage, and a retrievable audit trail.

Core Components Every Professional Consent Form Should Include

A robust consent form addresses participant rights, study details, data uses, signatures, and compliance requirements.

Study Overview

Clear description of purpose, duration, and what participation involves, written in plain language for participant comprehension.

Risks and Benefits

Concise listing of foreseeable risks and potential benefits, including device-specific safety considerations and expected outcomes.

Data Use and Sharing

Explicit permissions for collection, storage, secondary use, and third-party disclosures, with HIPAA authorization where applicable.

Voluntary Participation

Statement that participation is voluntary and withdrawal will not affect standard care, with instructions for withdrawing consent.

Signature and Date

Signature block for participant or legally authorized representative, plus date, printed name, and contact information.

Contact Information

Provide study team and IRB contact details for questions, complaints, and participant rights inquiries.

Frequently Asked Questions and Common Issues

Answers to common questions about legality, HIPAA, notarization, and correcting executed consents.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users